Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 236 member A (FAM236A)
- Target
- FAM236A
- Molecular classification
- Other (no clear, characterized protein family beyond sequence similarity grouping), It is not classified as a receptor, enzyme, transporter, ion channel, transcription factor, or other well-defined protein family based on current data
01
Overview
Family with sequence similarity 236 member A (FAM236A) is a protein-coding gene annotated in human genomics databases. It is part of a poorly characterized family of proteins defined by sequence homology. FAM236A has a number of aliases and previous gene symbols—including DMRTC1-AS1 and LINC00684—which arose due to changing annotation, particularly regarding non-coding versus coding status. The protein has no known molecular function, biological role, or disease implication; it lacks defined domains, structural motifs, or interaction partners with known pharmacological relevance. No interacting drugs, biomarker applications, or safety concerns have been identified to date in curated biomedical databases or recent literature[3][2][5].
- Other names
- FAM236ADMRTC1-AS1LINC00684Protein FAM236AFamily with sequence similarity 235 member ALong intergenic non-protein coding RNA 684DMRTC1 antisense RNA 1 (non-protein coding)
02
Mechanism of action
None; no mechanism of action for drugs or biologics is available for this protein
03
Biological functions
Unknown; the biological function has not been well characterized and is not defined in any major resources, annotations, or functional genomics studies
04
Disease associations
None; there are no reported specific disease associations or roles in pathological mechanisms in curated human disease databases
05
Safety considerations
None; there are no known safety concerns, therapeutic liabilities, or clinical adverse events associated with this protein
06
Interacting drugs
None; there are no drugs, chemical probes, or biologics reported to directly interact with or target FAM236A
07
Biomarkers
None; FAM236A is not reported as a biomarker for patient selection, disease progression, or therapeutic efficacy monitoring in medical or research literature
Beyond the preview
Go deeper on Family with sequence similarity 236 member A (FAM236A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Family with sequence similarity 236 member A (FAM236A).